Hydrogen Sulfide Ameliorates SARS-CoV-2-Associated Lung Endothelial Barrier Disruption.

Similarly, when we calculated the barrier-altering effect of GYY4137 treatment after plasma treatment, we only detected a slightly increasing trend towards the more severe disease groups, but this trend did not reach the level of statistical difference ( Figure 3 B).

also in 233 other papers